US Patent 9504236 Animal models and therapeutic molecules
Patent 9504236 was granted and assigned to Kymab on November, 2016 by the United States Patent and Trademark Office.
All edits
Edits on 12 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 6 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 5 Dec, 2023
Golden AI
Edits made to:
Article (+309 characters)
Article
Patent abstract
The invention pertains to a transgenic non-human mammal which contains a chimeric immunoglobulin locus containing human variable region gene segments at an endogenous Ig locus operatively linked to non-human mammalian constant region genes, and methods to produce chimeric antibodies therefrom.
Edits on 29 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Allan Bradley0
E-Chiang Lee0
Qi Liang0
Wei Wang0
Edits on 26 Jul, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09504236 Animal models and therapeutic molecules US Patent 9504236 Animal models and therapeutic molecules
Infobox
Patent Number
09504236
Patent Number
9504236
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 9 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09504236 Animal models and therapeutic molecules
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09504236
Date of patent
November 29, 2016
Patent application number
14935010
Date Filed
November 6, 2015
Patent primary examiner
Find more entities like US Patent 9504236 Animal models and therapeutic molecules
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
